NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ: NTHI · Real-Time Price · USD
16.55
+4.55 (37.92%)
At close: Mar 28, 2025 - Market closed
Company Description
NeOnc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases in the United States.
The company offers products, including NEO100, a purified form of perillyl acid administered intranasally to treat brain cancer patients, and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol.
NeOnc Technologies Holdings, Inc. was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009.
The company was founded in 2008 and is based in Westlake Village, California.
NeOnc Technologies Holdings, Inc.
| Country | United States |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 8 |
| CEO | Thomas Chen |
Contact Details
Address: Two Dole Drive Westlake Village, California 91362 United States | |
| Phone | 310-663-7831 |
| Website | neonctech.com |
Stock Details
| Ticker Symbol | NTHI |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001979414 |
| Employer ID | 92-1954864 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Thomas Chen | Chief Executive Officer |
| Keithly Garnett | Chief Financial Officer |
| Patrick Walters | Chief Operating Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 27, 2025 | 8-K | Current Report |
| Mar 26, 2025 | CERT | Certification by an exchange approving securities for listing |
| Mar 25, 2025 | EFFECT | Notice of Effectiveness |
| Mar 25, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 25, 2025 | 424B4 | Prospectus |
| Mar 24, 2025 | 8-A12B | Registration of securities |
| Mar 24, 2025 | D | Notice of Exempt Offering of Securities |
| Feb 26, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jan 31, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jan 3, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |